Eastman Chemical (EMN) has quietly lagged the broader market this year, but its recent bounce over the past month has some investors revisiting the stock as a potential value opportunity.

That recent 30 day share price return of 6.77% looks more like a short term relief move than a trend change, given the year to date share price return is still down 28.20% and the five year total shareholder return sits firmly in negative territory.

If Eastman’s recent move has you rethinking your watchlist, this could be a good moment to look beyond chemicals and scout fast growing stocks with high insider ownership for other compelling stories.

With earnings still growing modestly and the share price heavily lagging, Eastman screens cheap on several valuation lenses. The question is whether investors are looking at a mispriced turnaround or a business where the market already doubts future growth.

Most Popular Narrative: 13% Undervalued

With Eastman Chemical shares last closing at $63.56 versus a narrative fair value near $72.76, the story hinges on whether earnings can sustainably inflect higher.

Implementation of cost reduction initiatives ($75M-$100M in ongoing savings), strategic asset optimization (such as the ethylene to propylene project), and disciplined portfolio management is likely to lead to improving net margins and higher ROIC, especially as end market demand recovers and utilization rates normalize.

Curious how modest revenue assumptions can still justify a richer future earnings multiple, despite today’s weak backdrop and rising cash returns to shareholders? The narrative’s projections about margins, utilization and share count may surprise you.

Result: Fair Value of $72.76 (UNDERVALUED)

However, lingering trade tensions and weaker than expected uptake of Eastman’s recycled materials could delay margin expansion and keep the valuation discount intact.

Build Your Own Eastman Chemical Narrative

If you see the story differently or want to stress test your own assumptions, you can build a personalized view in under three minutes: Do it your way.

A great starting point for your Eastman Chemical research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.

Looking for more investment ideas?

Before you move on, lock in a few fresh opportunities by using the Simply Wall St screener, so you are not relying on just one story.

• Boost your potential upside by targeting mispriced companies through these 914 undervalued stocks based on cash flows that pair strong cash flows with attractive entry points.
• Accelerate your growth hunt with these 24 AI penny stocks that capture the momentum of businesses shaping the next wave of artificial intelligence.
• Strengthen your income stream by scanning these 12 dividend stocks with yields > 3% that offer reliable yields above 3% backed by real fundamentals.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.